A Comparative Analysis on the Doses of Covaxin and Covishield Vaccines Administered in India

Abstract

Abstract: The world has been struggling with the outbreak of Covid- 19 virus for past 21 months. It is a severe acute respiratory syndrome caused by a highly transmissible novel coronavirus. Every country, including India adopted certain measures to combat the pandemic, like announcing lockdown in phases. India has been severely struck by the Covid pandemic. In fact, the third wave of Covid has already knocked in. The development of vaccines against the Covid virus helped the world heal. Different countries are testing the Covid vaccine candidates. The world’s largest vaccination drive started in India on January 16, 2021. The Indian Government has taken a great step forward to vaccinate every individual along with manufacturing the Covid vaccine domestically. The Government of India has also taken effective measures to launch a digital platform Aarogya Setu for the vaccine registration and obtaining the proof that the individual has been vaccinated with the name of the vaccine given and the date on which he/she got vaccinated. In this paper, we have studied the use of Covaxin and Covishield doses in different states of India and found that people who received both doses of the Covid vaccination, whether Covishield or Covaxin, are safe against the Covid virus, according to the government, but they must follow the covid protocols for best outcomes.